Long-Term Safety and Effectiveness of Subcutaneous Injections of Apomorphine in the Treatment of "Off" Episodes in Patients With "On-Off" or "Wearing-Off" Effects Associated With Late-Stage Parkinson's Disease
Latest Information Update: 24 Aug 2020
At a glance
- Drugs Apomorphine (Primary)
- Indications Parkinson's disease
- Focus Adverse reactions
- Sponsors Bertek Pharmaceuticals; Mylan Pharmaceuticals
Most Recent Events
- 17 Jan 2020 New trial record